Nantahala holds 4.72% of Verastem (NASDAQ: VSTM) shares
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Nantahala Capital Management, LLC and its principals report a significant but sub‑5% stake in Verastem, Inc. They disclose beneficial ownership of 3,795,473 shares of Verastem common stock, representing 4.72% of the outstanding class as of December 31, 2025.
The filing states that Nantahala, Wilmot B. Harkey, and Daniel Mack share voting and dispositive power over these shares and have no sole voting or dispositive authority. They certify that the securities were acquired and are held in the ordinary course of business, not to change or influence control of Verastem.
Positive
- None.
Negative
- None.
FAQ
What stake in Verastem (VSTM) does Nantahala Capital report in this Schedule 13G/A?
Nantahala Capital and its principals report beneficial ownership of 3,795,473 Verastem shares, equal to 4.72% of the common stock as of December 31, 2025. This reflects a significant institutional position while remaining below the 5% threshold.
Who are the reporting persons in the Verastem (VSTM) Schedule 13G/A filing?
The reporting persons are Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack. Nantahala is a Massachusetts limited liability company, and Harkey and Mack are U.S. citizens associated with Nantahala’s investment management activities in Verastem shares.
What does the Verastem (VSTM) Schedule 13G/A say about intent to influence control?
The filers certify the Verastem shares were acquired and are held in the ordinary course of business. They state the holdings are not for the purpose of changing or influencing control of Verastem and not in connection with any control-related transaction.
On what date is the Verastem (VSTM) ownership information measured in this filing?
The ownership information is measured as of December 31, 2025. On that date, Nantahala and its principals report beneficial ownership of 3,795,473 Verastem common shares, representing 4.72% of the outstanding stock for Schedule 13G/A reporting purposes.
Does the Verastem (VSTM) Schedule 13G/A indicate ownership of more than 5% of the stock?
No. The filing specifies that each reporting person beneficially owns 4.72% of Verastem’s common stock. Item 5 confirms ownership of 5 percent or less of the class, placing the position just under the regulatory 5% reporting threshold.